🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A LMIC perspective on managing adverse events in haematological malignancy. Privileged to lead this The Lancet paper with authors from Argentina, Brazil, Zambia and Kenya. A wonderful experience. Tata Memorial Hospital thelancet.com/journals/lanha…

POLCA GB#ASCO 2025 “ A GameChanger” We selected & defined patients of locally advanced Gallbladder Cancer as per predefined “TMH Criteria” and showed neoadjuvant strategies work to improve outcomes.

ASCO 2025 is all about Immunotherapy which is showing results that are grabbing attention across all sites. However 84%of the world are in the LMICs. Wonder how and when will these IOs reach the large majority.

Stunning view of Mahendragiri, Odisha’s second-highest mountain peak. Mahendragiri, a part of the Eastern Ghats, is a biodiversity heritage site in Odisha.

#ASCO25 First RCT on steroid duration in mild ICI-pneumonitis 3-w vs 6-w corticosteroid therapy 👥 n:105 (G 1–2 pneumonitis) ✅ Tx success at 8 wks: 66.7% vs 85.2% → Non-inferiority not met❗️ 🔁 Relapse rate: 41% vs 24% ❗️Shorter 3-week regimen cannot replace standard

Photo of the year for myeloma: Cilta-cel in multi-drug refractory disease From Jagannath, Plasma Cell Pete et al Journal of Clinical Oncology #ASCO25

To find happiness…

A full-day review meeting was held today at NISER with teams from Tata Memorial Centre, Tata Steel Foundation, TSUIL, CPWD, and RJB to assess progress on the upcoming Tata Memorial Centre Hospital in Jatani. Productive discussions, detailed planning, and an insightful site visit.

The richest man is also not happy.

Thank you Richard Lehman and Ian Davis (Bluesky @profiand) . I hugely respect you both, and have learned a lot from you both. The inspiration for writing oncology blogs came from Richard. Reading your weekly BMJ blogs was my first introduction to critical appraisal which led me to the epiphany

🚨 CAST trial from Australia-New Zealand - A practise changing one! PTCY with CNI - A new SOC for MSD transplants. Anti-metabolites can “rest in peace”! Below is the comparisons between BMT CTN 1703, HOVON-96 and CAST study. #bmt NEJM

🏄‍♂️Benefit vs Harm! How to treat stage-II seminoma? An in-depth review⬇️ OncoAlert Yüksel Ürün Beliz Bahar Karaoğlan #cancer #Oncology #testicularcancer #MedTwitter #MedX JCO Oncology Practice doi.org/10.1200/OP-25-…

EHA 2025 - ECHO trial: nice to be part of an international effort thanks to our patients and wonderful team at FUNDALEU

2nd Annual Cancer Congress of TMC Punjab - Homi Bhabha Cancer Conclave - 2025. Please block your dates. ⁦ACTREC-TMC⁩ ⁦TMH Medical Oncology Alumni⁩ ⁦Tata Memorial Centre, Varanasi (MPMMCC & HBCH)⁩ ⁦TMC Radiation Oncology⁩

With just one day to go for International Day of Yoga 2025, the excitement is palpable at Tata Memorial Centre The pediatric cancer patients have been rehearsing with joy and focus, guided by compassionate instructors who’ve made wellness a fun and empowering journey. Every

Why does cytarabine hit the brain so hard? 🧠It causes DSBs, especially in Purkinje cells! Meanwhile, Gemcitabine plays much nicer! Check out our paper in Nature today! Huge thanks to my mentor André Nussenzweig andre nussenzweig lab and all my amazing colleagues! nature.com/articles/s4158…

Gear up for the hugely popular BHC (Basic Hematopathology Course (BHC), 2025! Less than 3 weeks to go! Date: 18th & 19th July, 2025 Venue: ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai Registration will be capped at 250! Only a few spots left!! shorturl.at/mjrdy

Excited to share two advances that bring us closer to real-world impact in healthcare AI: SDBench introduces a new benchmark that transforms 304 NEJM cases into interactive diagnostic simulations. AI must ask questions, order tests, and weigh costs, mirroring the complexity of

First do no harm. Sorry for the typo

The typo was scary 😟!!!